Hypophosphatasia: an overview of the disease and its treatment
- PMID: 26245849
- DOI: 10.1007/s00198-015-3272-1
Hypophosphatasia: an overview of the disease and its treatment
Abstract
This review presents the current knowledge on hypophosphatasia, a rare genetic disease of very variable severity (from lethal to mild) and clinical presentation, caused by defective production of tissue-non-specific alkaline phosphatase (TNSALP). Hypophosphatasia can affect babies in utero as well as infants, children, and adults. The article first presents the genetics of TNSALP and its many known mutations underlying the disease. Then, it presents the epidemiology, classification, and clinical presentation of the six different forms of the disease (perinatal lethal, prenatal benign, infantile, childhood, adult, and odontohypophosphatasia) as well as the essential diagnostic clues. The last section on treatment presents a survey of the therapeutic approaches, up to the ongoing phase 2 studies of enzyme replacement therapy.
Keywords: Alkaline phosphatase; Bone; Fractures; Hypomineralization; Hypophosphatasia; Teeth.
Similar articles
-
Alkaline Phosphatase Replacement Therapy.Adv Exp Med Biol. 2019;1148:201-232. doi: 10.1007/978-981-13-7709-9_10. Adv Exp Med Biol. 2019. PMID: 31482501 Review.
-
Hypophosphatasia in adolescents and adults: overview of diagnosis and treatment.Osteoporos Int. 2020 Aug;31(8):1445-1460. doi: 10.1007/s00198-020-05345-9. Epub 2020 Mar 11. Osteoporos Int. 2020. PMID: 32162014 Review.
-
Hypophosphatasia.Orphanet J Rare Dis. 2007 Oct 4;2:40. doi: 10.1186/1750-1172-2-40. Orphanet J Rare Dis. 2007. PMID: 17916236 Free PMC article. Review.
-
[Hypophosphatasia : What is currently available for treatment?].Internist (Berl). 2016 Dec;57(12):1145-1154. doi: 10.1007/s00108-016-0147-2. Internist (Berl). 2016. PMID: 27796472 Review. German.
-
Prenatal genetic diagnosis of severe perinatal (lethal) hypophosphatasia.J Nippon Med Sch. 2007 Feb;74(1):65-9. doi: 10.1272/jnms.74.65. J Nippon Med Sch. 2007. PMID: 17384481
Cited by
-
Dental manifestation and management of hypophosphatasia.Jpn Dent Sci Rev. 2022 Nov;58:208-216. doi: 10.1016/j.jdsr.2022.06.002. Epub 2022 Jul 2. Jpn Dent Sci Rev. 2022. PMID: 35814738 Free PMC article. Review.
-
Prevalence of chondrocalcinosis and calcium pyrophosphate deposition disease in a cohort of adult patients with low alkaline phosphatase levels and a positive versus negative genetic ALPL study.JBMR Plus. 2024 Sep 26;8(11):ziae124. doi: 10.1093/jbmrpl/ziae124. eCollection 2024 Nov. JBMR Plus. 2024. PMID: 39450343 Free PMC article.
-
Not just a carrier: Clinical presentation and management of patients with heterozygous disease-causing alkaline phosphatase (ALPL) variants identified through expanded carrier screening.Mol Genet Genomic Med. 2023 Jan;11(1):e2056. doi: 10.1002/mgg3.2056. Epub 2022 Nov 28. Mol Genet Genomic Med. 2023. PMID: 36444396 Free PMC article.
-
Not Your Typical Bisphosphonate Intolerance: A Case of Unusual Bone Pain With Low Alkaline Phosphatase.Cureus. 2022 Mar 14;14(3):e23163. doi: 10.7759/cureus.23163. eCollection 2022 Mar. Cureus. 2022. PMID: 35444911 Free PMC article.
-
Neurological symptoms in Hypophosphatasia.Osteoporos Int. 2019 Feb;30(2):469-480. doi: 10.1007/s00198-018-4691-6. Epub 2018 Sep 13. Osteoporos Int. 2019. PMID: 30215116
References
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources